121 related articles for article (PubMed ID: 19183615)
1. In vivo photosensitizer tomography inside the human prostate.
Axelsson J; Swartling J; Andersson-Engels S
Opt Lett; 2009 Feb; 34(3):232-4. PubMed ID: 19183615
[TBL] [Abstract][Full Text] [Related]
2. Combination of Fospeg-IPDT and a natural antioxidant compound prevents photosensitivity in a murine prostate cancer tumour model.
Petri A; Alexandratou E; Kyriazi M; Rallis M; Roussis V; Yova D
Photodiagnosis Photodyn Ther; 2012 Jun; 9(2):100-8. PubMed ID: 22594979
[TBL] [Abstract][Full Text] [Related]
3. mTHPC-mediated photodynamic diagnosis of malignant brain tumors.
Zimmermann A; Ritsch-Marte M; Kostron H
Photochem Photobiol; 2001 Oct; 74(4):611-6. PubMed ID: 11683042
[TBL] [Abstract][Full Text] [Related]
4. Effective treatment of liver metastases with photodynamic therapy, using the second-generation photosensitizer meta-tetra(hydroxyphenyl)chlorin (mTHPC), in a rat model.
Rovers JP; Saarnak AE; Molina A; Schuitmaker JJ; Sterenborg HJ; Terpstra OT
Br J Cancer; 1999 Oct; 81(4):600-8. PubMed ID: 10574244
[TBL] [Abstract][Full Text] [Related]
5. System for interstitial photodynamic therapy with online dosimetry: first clinical experiences of prostate cancer.
Swartling J; Axelsson J; Ahlgren G; Kälkner KM; Nilsson S; Svanberg S; Svanberg K; Andersson-Engels S
J Biomed Opt; 2010; 15(5):058003. PubMed ID: 21054129
[TBL] [Abstract][Full Text] [Related]
6. Schedule-dependent interaction between Doxorubicin and mTHPC-mediated photodynamic therapy in murine hepatoma in vitro and in vivo.
Kirveliene V; Grazeliene G; Dabkeviciene D; Micke I; Kirvelis D; Juodka B; Didziapetriene J
Cancer Chemother Pharmacol; 2006 Jan; 57(1):65-72. PubMed ID: 16001168
[TBL] [Abstract][Full Text] [Related]
7. Photodynamic therapy for prostate cancer--a review of current status and future promise.
Moore CM; Pendse D; Emberton M
Nat Clin Pract Urol; 2009 Jan; 6(1):18-30. PubMed ID: 19132003
[TBL] [Abstract][Full Text] [Related]
8. Localization of liposomal mTHPC formulations within normal epithelium, dysplastic tissue, and carcinoma of oral epithelium in the 4NQO-carcinogenesis rat model.
de Visscher SA; Witjes MJ; van der Vegt B; de Bruijn HS; van der Ploeg-van den Heuvel A; Amelink A; Sterenborg HJ; Roodenburg JL; Robinson DJ
Lasers Surg Med; 2013 Dec; 45(10):668-78. PubMed ID: 24174342
[TBL] [Abstract][Full Text] [Related]
9. MR and CT based treatment planning for mTHPC mediated interstitial photodynamic therapy of head and neck cancer: description of the method.
Karakullukcu B; van Veen RL; Aans JB; Hamming-Vrieze O; Navran A; Teertstra HJ; van den Boom F; Niatsetski Y; Sterenborg HJ; Tan IB
Lasers Surg Med; 2013 Oct; 45(8):517-23. PubMed ID: 24037957
[TBL] [Abstract][Full Text] [Related]
10. Photodynamic therapy as novel nephron sparing treatment option for small renal masses.
Kroeze SG; Grimbergen MC; Rehmann H; Bosch JL; Jans JJ
J Urol; 2012 Jan; 187(1):289-95. PubMed ID: 22099991
[TBL] [Abstract][Full Text] [Related]
11. mTHPC mediated, systemic photodynamic therapy (PDT) for nonmelanoma skin cancers: Case and literature review.
Horlings RK; Terra JB; Witjes MJ
Lasers Surg Med; 2015 Dec; 47(10):779-87. PubMed ID: 26462858
[TBL] [Abstract][Full Text] [Related]
12. mTHPC--a drug on its way from second to third generation photosensitizer?
Senge MO
Photodiagnosis Photodyn Ther; 2012 Jun; 9(2):170-9. PubMed ID: 22594988
[TBL] [Abstract][Full Text] [Related]
13. Inclusion complexation with β-cyclodextrin derivatives alters photodynamic activity and biodistribution of meta-tetra(hydroxyphenyl)chlorin.
Yankovsky I; Bastien E; Yakavets I; Khludeyev I; Lassalle HP; Gräfe S; Bezdetnaya L; Zorin V
Eur J Pharm Sci; 2016 Aug; 91():172-82. PubMed ID: 27320407
[TBL] [Abstract][Full Text] [Related]
14. Photodynamic therapy using meso tetra hydroxy phenyl chlorin (mTHPC) in early prostate cancer.
Moore CM; Nathan TR; Lees WR; Mosse CA; Freeman A; Emberton M; Bown SG
Lasers Surg Med; 2006 Jun; 38(5):356-63. PubMed ID: 16392142
[TBL] [Abstract][Full Text] [Related]
15. Significantly increased lesion size by using the near-infrared photosensitizer 5,10,15,20-tetrakis (m-hydroxyphenyl)bacteriochlorin in interstitial photodynamic therapy of normal rat liver tissue.
Rovers JP; de Jode ML; Grahn MF
Lasers Surg Med; 2000; 27(3):235-40. PubMed ID: 11013385
[TBL] [Abstract][Full Text] [Related]
16. Photodynamic therapy of a transplanted pancreatic cancer model using meta-tetrahydroxyphenylchlorin (mTHPC).
Mikvy P; Messman H; MacRobert AJ; Pauer M; Sams VR; Davies CL; Stewart JC; Bown SG
Br J Cancer; 1997; 76(6):713-8. PubMed ID: 9310235
[TBL] [Abstract][Full Text] [Related]
17. Experimental photodynamic therapy for malignant pleural mesothelioma with pegylated mTHPC.
Krueger T; Altermatt HJ; Mettler D; Scholl B; Magnusson L; Ris HB
Lasers Surg Med; 2003; 32(1):61-8. PubMed ID: 12516073
[TBL] [Abstract][Full Text] [Related]
18. Experimental assessment of photodynamic therapy with chlorins for malignant mesothelioma.
Ris HB; Giger A; Hof VI; Mettler D; Stewart JC; Althaus U; Altermatt HJ
Eur J Cardiothorac Surg; 1997 Oct; 12(4):542-8. PubMed ID: 9370396
[TBL] [Abstract][Full Text] [Related]
19. Effects of chlorin-mediated photodynamic therapy combined with fluoropyrimidines in vitro and in a patient.
Zimmermann A; Walt H; Haller U; Baas P; Klein SD
Cancer Chemother Pharmacol; 2003 Feb; 51(2):147-54. PubMed ID: 12647016
[TBL] [Abstract][Full Text] [Related]
20. Interstitial and transurethral photodynamic therapy of the canine prostate using meso-tetra-(m-hydroxyphenyl) chlorin.
Chang SC; Buonaccorsi G; MacRobert A; Bown SG
Int J Cancer; 1996 Aug; 67(4):555-62. PubMed ID: 8759616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
